These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15808801)

  • 1. Levetiracetam use and pregnancy outcome.
    ten Berg K; Samrén EB; van Oppen AC; Engelsman M; Lindhout D
    Reprod Toxicol; 2005; 20(1):175-8. PubMed ID: 15808801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register.
    Hunt S; Craig J; Russell A; Guthrie E; Parsons L; Robertson I; Waddell R; Irwin B; Morrison PJ; Morrow J
    Neurology; 2006 Nov; 67(10):1876-9. PubMed ID: 17130430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teratogenicity of the newer antiepileptic drugs--the Australian experience.
    Vajda FJ; Graham J; Roten A; Lander CM; O'Brien TJ; Eadie M
    J Clin Neurosci; 2012 Jan; 19(1):57-9. PubMed ID: 22104350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy, delivery, and outcome for the child in maternal epilepsy.
    Veiby G; Daltveit AK; Engelsen BA; Gilhus NE
    Epilepsia; 2009 Sep; 50(9):2130-9. PubMed ID: 19490036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam-induced thrombocytopenia among inpatients: a retrospective study.
    Sahaya K; Goyal MK; Sarwal A; Singh NN
    Epilepsia; 2010 Dec; 51(12):2492-5. PubMed ID: 21204814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotoxic effects of prenatal exposure to levetiracetam during pregnancy on rat offsprings.
    Tural S; Tekcan A; Elbistan M; Karakuş N; Ozyurek H; Kara N
    In Vivo; 2015; 29(1):77-81. PubMed ID: 25600534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam monotherapy during pregnancy: a case series.
    Long L
    Epilepsy Behav; 2003 Aug; 4(4):447-8. PubMed ID: 12899868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate teratogenicity and epilepsy syndrome.
    Bromfield EB; Dworetzky BA; Wyszynski DF; Smith CR; Baldwin EJ; Holmes LB
    Epilepsia; 2008 Dec; 49(12):2122-4. PubMed ID: 18557775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Keppra in pregnancy. Generally lower risk of birth defects in monotherapy].
    Seidel P; Schneede J
    Lakartidningen; 2012 May 30-Jun 4; 109(22):1099. PubMed ID: 22808661
    [No Abstract]   [Full Text] [Related]  

  • 11. Child development following in utero exposure: levetiracetam vs sodium valproate.
    Shallcross R; Bromley RL; Irwin B; Bonnett LJ; Morrow J; Baker GA; ;
    Neurology; 2011 Jan; 76(4):383-9. PubMed ID: 21263139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy.
    Viinikainen K; Heinonen S; Eriksson K; Kälviäinen R
    Epilepsia; 2006 Jan; 47(1):186-92. PubMed ID: 16417548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant teratogenesis: 2. Statistical methods for multiple birth outcomes.
    Legler JM; Ryan LM; Harvey EA; Holmes LB
    Teratology; 1994 Jul; 50(1):74-9. PubMed ID: 7974257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.
    von Stuelpnagel C; Holthausen H; Kluger G
    Eur J Paediatr Neurol; 2007 Nov; 11(6):341-5. PubMed ID: 17442601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam extended release and levetiracetam immediate release as adjunctive treatment for partial-onset seizures: an indirect comparison of treatment-emergent adverse events using meta-analytic techniques.
    Richy FF; Banerjee S; Brabant Y; Helmers S
    Epilepsy Behav; 2009 Oct; 16(2):240-5. PubMed ID: 19699156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive and negative psychotropic effects of levetiracetam.
    Helmstaedter C; Fritz NE; Kockelmann E; Kosanetzky N; Elger CE
    Epilepsy Behav; 2008 Oct; 13(3):535-41. PubMed ID: 18583196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
    Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
    Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of levetiracetam on challenging behavior.
    Hurtado B; Koepp MJ; Sander JW; Thompson PJ
    Epilepsy Behav; 2006 May; 8(3):588-92. PubMed ID: 16473557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: A Danish nationwide cohort study.
    Langagergaard V; Pedersen L; Gislum M; Nørgard B; Sørensen HT
    Aliment Pharmacol Ther; 2007 Jan; 25(1):73-81. PubMed ID: 17229222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam pharmacokinetics in neonates at birth.
    Allegaert K; Lewi L; Naulaers G; Lagae L
    Epilepsia; 2006 Jun; 47(6):1068-9. PubMed ID: 16822254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.